Agustina Forastiero - Concepedia

Author

Agustina Forastiero

Instituto de Salud Carlos III ORCID

Also Known As

A. Forastiero, Agustina Forastiero

Publications

553

Citations

H-Index

Concepts

All Affiliations

Instituto de Salud Carlos III Centro Nacional de Microbiologia Hospital Británico de Buenos Aires Universidad de Antioquia Hospital General Universitario Gregorio Marañón

About

Agustina Forastiero is an author at Instituto de Salud Carlos III specializing in medicine, microbiology, and antifungal agents.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	234
2	Microbiology	3	3	191
3	Biology	1	1	43
4	Molecular Genetics	1	1	43
5	Pathology	1	1	121

Agustina Forastiero

Publications

441

Citations

H-Index

Page 1

	Year	Citations
Candida tropicalis Antifungal Cross-Resistance Is Related to Different Azole Target (Erg11p) Modifications Agustina Forastiero, Ana Cecilia Mesa-Arango, Ana Alastruey‐Izquierdo, Antimicrobial Agents and Chemotherapy	2013	130
The non-mammalian host<i>Galleria mellonella</i>can be used to study the virulence of the fungal pathogen<i>Candida tropicalis</i>and the efficacy of antifungal drugs during infection by this pathogenic yeast Ana Cecilia Mesa-Arango, Agustina Forastiero, Leticia Bernal‐Martínez, Medical Mycology Pathogenic MicrobiologyMicrobial PathogensPathologyBacterial PathogensC. Tropicalis Virulence	2012	121
Rapid Development of Candida krusei Echinocandin Resistance during Caspofungin Therapy Agustina Forastiero, V. Garcia-Gil, Olga Rivero-Menéndez, Antimicrobial Agents and Chemotherapy	2015	60
HPLC/UV or bioassay: two valid methods for posaconazole quantification in human serum samples Emilio Cendejas‐Bueno, Agustina Forastiero, J. L. Rodríguez-Tudela, Clinical Microbiology and Infection Human Serum SamplesAntifungal AgentsBioanalysisPharmacologyChemical Pathology	2011	43
An invertebrate model to evaluate virulence in Aspergillus fumigatus: The role of azole resistance Alicia Gómez‐López, Agustina Forastiero, Emilio Cendejas‐Bueno, Medical Mycology BiologyBiosynthesisAzole ResistanceAspergillus FumigatusInsect Larvae	2014	43
In vivo efficacy of voriconazole and posaconazole therapy in a novel invertebrate model of Aspergillus fumigatus infection Agustina Forastiero, Leticia Bernal‐Martínez, Emilia Mellado, International Journal of Antimicrobial Agents Aspergillus Fumigatus InfectionAntifungal AgentPosaconazole TherapyAntifungal AgentsMedicine	2015	27
Etest ECVs/ECOFFs for Detection of Resistance in Prevalent and Three Nonprevalent <i>Candida</i> spp. to Triazoles and Amphotericin B and Aspergillus spp. to Caspofungin: Further Assessment of Modal Variability Ana Espinel‐Ingroff, Milène Sasso, John Turnidge, Antimicrobial Agents and Chemotherapy	2021	17

Page 1